{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:38:59Z","timestamp":1776789539623,"version":"3.51.2"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (NHMRC), Australia","doi-asserted-by":"publisher","award":["G1600298"],"award-info":[{"award-number":["G1600298"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001081","name":"Hunter Medical Research Institute, New South Wales, Australia. GAJ is supported by the","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001081","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Drug Abuse U.S. Public Health Service award","award":["R01 DA006214"],"award-info":[{"award-number":["R01 DA006214"]}]},{"name":"Charlotte and Murray Strongwater Endowment for Neuroscience and Brain Health"},{"DOI":"10.13039\/501100000925","name":"NHMRC CJ Martin Fellowship","doi-asserted-by":"publisher","award":["1072706"],"award-info":[{"award-number":["1072706"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.neuropharm.2018.09.033","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T12:06:17Z","timestamp":1537617977000},"page":"22-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Activation of lateral hypothalamic group III metabotropic glutamate receptors suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin\/hypocretin cells"],"prefix":"10.1016","volume":"154","author":[{"given":"Jiann W.","family":"Yeoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan H.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron D.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaideep S.","family":"Bains","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Aston-Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett A.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher V.","family":"Dayas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.09.033_bib1","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1523\/JNEUROSCI.5416-03.2004","article-title":"Group III metabotropic glutamate receptors maintain tonic inhibition of excitatory synaptic input to hypocretin\/orexin neurons","volume":"24","author":"Acuna-Goycolea","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib2","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/sj.npp.1301588","article-title":"Rats with extended access to cocaine exhibit increased stress reactivity and sensitivity to the anxiolytic-like effects of the mGluR 2\/3 agonist LY379268 during abstinence","volume":"33","author":"Aujla","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s002130051028","article-title":"Corticotropin-releasing factor antagonist attenuates the \"anxiogenic-like\" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats","volume":"145","author":"Basso","year":"1999","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/cne.903190204","article-title":"The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization","volume":"319","author":"Bittencourt","year":"1992","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7266","article-title":"Antagonistic interplay between hypocretin and leptin in the lateral hypothalamus regulates stress responses","volume":"6","author":"Bonnavion","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib6","doi-asserted-by":"crossref","first-page":"11215","DOI":"10.1523\/JNEUROSCI.6096-08.2009","article-title":"Orexin A\/hypocretin-1 selectively promotes motivation for positive reinforcers","volume":"29","author":"Borgland","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2018.07.027","article-title":"Hypocretin receptor 1 involvement in cocaine-associated behavior: therapeutic potential and novel mechanistic insights","author":"Brodnik","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuropharm.2014.07.007","article-title":"Role of orexin\/hypocretin in conditioned sucrose-seeking in female rats","volume":"86","author":"Cason","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchemneu.2015.03.002","article-title":"Distribution of the orexin-1 receptor (OX1R) in the mouse forebrain and rostral brainstem: a characterisation of OX1R-eGFP mice","volume":"66\u201367","author":"Ch'ng","year":"2015","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(98)00977-X","article-title":"Orexin A-like immunoreactivity in the rat brain","volume":"260","author":"Chen","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1300\/J069v20n03_05","article-title":"Cocaine sensitization and craving: differing roles for dopamine and glutamate in the nucleus accumbens","volume":"20","author":"Cornish","year":"2001","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biopsych.2007.02.002","article-title":"Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse","volume":"63","author":"Dayas","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib13","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.1085","article-title":"Characterization of CART neurons in the rat and human hypothalamus","volume":"432","author":"Elias","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1460-9568.2009.07065.x","article-title":"The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system","volume":"31","author":"Espana","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib16","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/j.celrep.2016.05.057","article-title":"Afferent inputs to neurotransmitter-defined cell types in the ventral tegmental area","volume":"15","author":"Faget","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib17","series-title":"The Glutamate Receptors","author":"Gereau","year":"2008"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib18","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1523\/JNEUROSCI.23-15-06223.2003","article-title":"Priming of excitatory synapses by alpha1 adrenoceptor-mediated inhibition of group III metabotropic glutamate receptors","volume":"23","author":"Gordon","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.physbeh.2004.10.011","article-title":"Incubation of sucrose craving: effects of reduced training and sucrose pre-loading","volume":"84","author":"Grimm","year":"2005","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.neuroscience.2007.11.018","article-title":"Renewal of extinguished cocaine-seeking","volume":"151","author":"Hamlin","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF02244345","article-title":"Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats","volume":"113","author":"Harris","year":"1993","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature04071","article-title":"A role for lateral hypothalamic orexin neurons in reward seeking","volume":"437","author":"Harris","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.physbeh.2013.10.005","article-title":"Optogenetic examination identifies a context-specific role for orexins\/hypocretins in anxiety-related behavior","volume":"130","author":"Heydendael","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2005.03.003","article-title":"Input organization and plasticity of hypocretin neurons: possible clues to obesity's association with insomnia","volume":"1","author":"Horvath","year":"2005","journal-title":"Cell Metabol."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0006-8993(99)01131-2","article-title":"Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats","volume":"821","author":"Ida","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1006\/bbrc.2000.2412","article-title":"Possible involvement of orexin in the stress reaction in rats","volume":"270","author":"Ida","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/7854_2016_56","article-title":"Role of the orexin\/hypocretin system in stress-related psychiatric disorders","volume":"33","author":"James","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib28","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1017\/S1461145711000423","article-title":"Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking","volume":"14","author":"James","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/7854_2016_57","article-title":"A decade of orexin\/hypocretin and addiction: where are we now?","volume":"33","author":"James","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib77","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.14166","article-title":"Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin\/hypocretin-1 receptor antagonist in rats","author":"James","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ijnp\/pyx107","article-title":"Cued reinstatement of cocaine but not sucrose seeking is dependent on dopamine signaling in prelimbic cortex and is associated with recruitment of prelimbic neurons that project to contralateral nucleus accumbens core","volume":"21","author":"James","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2016.05.013","article-title":"Rapamycin reduces motivated responding for cocaine and alters GluA1 expression in the ventral but not dorsal striatum","volume":"784","author":"James","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib32","article-title":"Increased number and activity of a lateral subpopulation of hypothalamic orexin\/hypocretin neurons underlies the expression of an addicted state in rats","author":"James","year":"2018","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib33","article-title":"Insights for developing pharmacological treatments for psychostimulant relapse targeting hypothalamic peptide systems","volume":"S4","author":"James","year":"2012","journal-title":"J. Addiction Res. Ther."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2826.2010.02020.x","article-title":"Metabotropic glutamate receptors: gatekeepers of homeostasis","volume":"22","author":"Kuzmiski","year":"2010","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuron.2009.05.027","article-title":"Metaplasticity of hypothalamic synapses following in vivo challenge","volume":"62","author":"Kuzmiski","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib36","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0196-9781(02)00251-6","article-title":"Measurement of hypocretin\/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background","volume":"23","author":"Lin","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib37","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1523\/JNEUROSCI.5584-07.2008","article-title":"Orexin signaling mediates the antidepressant-like effect of calorie restriction","volume":"28","author":"Lutter","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib38","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nn.3810","article-title":"Motivational activation: a unifying hypothesis of orexin\/hypocretin function","volume":"17","author":"Mahler","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00213-012-2681-5","article-title":"Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats","volume":"226","author":"Mahler","year":"2013","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0091-3057(00)00307-5","article-title":"Distinct inhibition of acute cocaine-stimulated motor activity following microinjection of a group III metabotropic glutamate receptor agonist into the dorsal striatum of rats","volume":"67","author":"Mao","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cne.1190","article-title":"Differential expression of orexin receptors 1 and 2 in the rat brain","volume":"435","author":"Marcus","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/adb.12441","article-title":"Differential role of hypothalamic orexin\/hypocretin neurons in reward seeking motivated by cocaine versus palatable food","volume":"23","author":"Martin-Fardon","year":"2018","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-3-642-28720-6_202","article-title":"Modeling relapse in animals","volume":"13","author":"Martin-Fardon","year":"2013","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/WNR.0000000000000120","article-title":"Blockade of hypocretin receptor-1 preferentially prevents cocaine seeking: comparison with natural reward seeking","volume":"25","author":"Martin-Fardon","year":"2014","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/j.neuropharm.2018.09.033_bib45","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/npp.2017.144","article-title":"Dorsal Hippocampus drives context-induced cocaine seeking via inputs to lateral septum","volume":"43","author":"McGlinchey","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib46","doi-asserted-by":"crossref","first-page":"8700","DOI":"10.1523\/JNEUROSCI.1291-15.2016","article-title":"Prelimbic to accumbens core pathway is recruited in a dopamine-dependent manner to drive cued reinstatement of cocaine seeking","volume":"36","author":"McGlinchey","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib47","doi-asserted-by":"crossref","first-page":"10493","DOI":"10.1523\/JNEUROSCI.3171-04.2004","article-title":"Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness","volume":"24","author":"Mieda","year":"2004","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2018.09.033_bib48","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/ejn.13170","article-title":"Orexin\/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner","volume":"43","author":"Moorman","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2016.10.018","article-title":"Orexin\/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats","volume":"1654","author":"Moorman","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib50","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib51","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib52","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1210\/er.2006-0021","article-title":"Expanding the scales: the multiple roles of MCH in regulating energy balance and other biological functions","volume":"27","author":"Pissios","year":"2006","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib53","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/npp.2013.72","article-title":"A role for hypocretin\/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior","volume":"38","author":"Plaza-Zabala","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib54","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1523\/JNEUROSCI.5724-09.2010","article-title":"Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior","volume":"30","author":"Plaza-Zabala","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib55","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.peptides.2010.04.020","article-title":"Interactions between orexin\u2013immunoreactive fibers and adrenaline or noradrenaline-expressing neurons of the lower brainstem in rats and mice","volume":"31","author":"Pusk\u00e1s","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib56","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1113\/jphysiol.2012.246983","article-title":"Repeated in vivo exposure of cocaine induces long-lasting synaptic plasticity in hypocretin\/orexin-producing neurons in the lateral hypothalamus in mice","volume":"591","author":"Rao","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib57","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1523\/JNEUROSCI.3917-11.2012","article-title":"Lateral hypothalamic orexin\/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference","volume":"32","author":"Richardson","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib58","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrn3837","article-title":"The role of orexin in motivated behaviours","volume":"15","author":"Sakurai","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib59","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib60","doi-asserted-by":"crossref","first-page":"17771","DOI":"10.1074\/jbc.274.25.17771","article-title":"Structure and function of human prepro-orexin gene","volume":"274","author":"Sakurai","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuron.2005.03.010","article-title":"Input of orexin\/hypocretin neurons revealed by a genetically encoded tracer in mice","volume":"46","author":"Sakurai","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-018-0054-4","article-title":"Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats","author":"Schmeichel","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib63","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.cub.2017.06.024","article-title":"Lateral hypothalamic GABAergic neurons encode reward predictions that are relayed to the ventral tegmental area to regulate learning","volume":"27","author":"Sharpe","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib64","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1460-9568.2009.06844.x","article-title":"Orexin\/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking","volume":"30","author":"Smith","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib65","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neuropharm.2009.06.042","article-title":"Orexin\/hypocretin is necessary for context-driven cocaine-seeking","volume":"58","author":"Smith","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib66","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.yhbeh.2013.12.014","article-title":"The orexin-1 receptor antagonist SB-334867 attenuates anxiety in rats exposed to cat odor but not the elevated plus maze: an investigation of Trial 1 and Trial 2 effects","volume":"65","author":"Staples","year":"2014","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib67","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neuropharm.2018.02.010","article-title":"Hypocretin\/orexin deficiency decreases cocaine abuse liability","volume":"133","author":"Steiner","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0167-0115(01)00344-5","article-title":"Orexins\/hypocretins in the ob\/ob mouse: hypothalamic gene expression, peptide content and metabolic effects","volume":"104","author":"Stricker-Krongrad","year":"2002","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib69","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbr.2014.10.028","article-title":"The orexin-1 receptor antagonist SB-334867 decreases anxiety-like behavior and c-Fos expression in the hypothalamus of rats exposed to cat odor","volume":"278","author":"Vanderhaven","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib70","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1124\/jpet.105.091512","article-title":"The CART (cocaine- and amphetamine-regulated transcript) system in appetite and drug addiction","volume":"320","author":"Vicentic","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib71","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0896-6273(03)00331-3","article-title":"Hypothalamic orexin neurons regulate arousal according to energy balance in mice","volume":"38","author":"Yamanaka","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.09.033_bib72","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0006-291X(03)00299-7","article-title":"Regulation of orexin neurons by the monoaminergic and cholinergic systems","volume":"303","author":"Yamanaka","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib73","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fnins.2014.00036","article-title":"Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls","volume":"8","author":"Yeoh","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib74","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fnbeh.2014.00280","article-title":"Electrophysiological characteristics of paraventricular thalamic (PVT) neurons in response to cocaine and cocaine- and amphetamine-regulated transcript (CART)","volume":"8","author":"Yeoh","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib75","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1113\/jphysiol.2012.230268","article-title":"Cocaine potentiates excitatory drive in the perifornical\/lateral hypothalamus","volume":"590","author":"Yeoh","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.09.033_bib76","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.111.187567","article-title":"Orexin-1 receptor mediation of cocaine seeking in male and female rats","volume":"340","author":"Zhou","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T13:13:38Z","timestamp":1720617218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818306968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":77,"alternative-id":["S0028390818306968"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.033","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/360081","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of lateral hypothalamic group III metabotropic glutamate receptors suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin\/hypocretin cells","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}